Global HIV AIDS 2020 Targets: 4 Alarming Failures Revealed
The global HIV AIDS 2020 targets set by UNAIDS will not be met, according to the 2020 Global AIDS Update presented at the International AIDS Conference virtual meeting. With 1.7 million people newly infected with HIV in 2019 alone, the world is three times above the 500,000 new infection target set for 2020. COVID-19 has compounded an already failing response, threatening to reverse years of hard won progress. According to the Mayo Clinic, HIV remains a major global health challenge affecting 38 million people worldwide, with no cure currently available.
Why the Global HIV AIDS 2020 Targets Were Already Off Track Before COVID-19
UNAIDS Executive Director Winnie Byanyima was direct in her assessment: progress toward ending AIDS as a public health threat by 2030 was already failing before COVID-19 arrived. The pandemic has since accelerated the crisis by disrupting supply chains, closing borders, and dismantling the community health operations that took years to build.
Modeling conducted on behalf of UNAIDS and the World Health Organization found that a six month disruption to medical supplies could result in an additional 500,000 AIDS related deaths in sub-Saharan Africa alone by the end of 2021. WHO Director-General Tedros Adhanom Ghebreyesus confirmed that 73 countries have reported running out of HIV medications, directly threatening whatever global HIV AIDS 2020 targets progress had been achieved over the previous decade.
As Byanyima stated plainly: one disease should not be sacrificed for another. Ghebreyesus echoed this, warning that while tackling COVID-19 is a global emergency, the world must not turn its back on the 38 million people living with HIV and the millions more at risk of infection.
The UNAIDS 90-90-90 Framework and Where It Stands
The global HIV AIDS 2020 targets are structured around three objectives known as the 90-90-90 targets. The first is diagnosing 90% of all individuals with HIV infection in each country. The second is starting 90% of those diagnosed on antiretroviral therapy. The third is achieving undetectable viral loads in 90% of patients receiving treatment.
Currently, 25.4 million of the 38 million people living with HIV are on treatment. That leaves 12.6 million people with HIV who are receiving no antiretroviral therapy at all. This treatment gap represents both a public health failure and a sustained transmission risk. Without reaching these 12.6 million people, the 90-90-90 framework that anchors the global HIV AIDS 2020 targets cannot be achieved.
To mitigate the impact of COVID-19 on antiretroviral access, WHO recommended that all countries prescribe antiretrovirals for longer periods, up to six months at a time. Ghebreyesus also suggested stockpiling condoms and drugs used for pre-exposure prophylaxis to reduce the risk of supply chain interruptions leading to treatment gaps.
4 Alarming Failures in the Global HIV AIDS 2020 Targets Report
1. New Infections Are Three Times the 2020 Target
The most alarming headline from the global HIV AIDS 2020 targets report is that 1.7 million new infections occurred in 2019, compared to the target of 500,000. This gap reflects structural failures in prevention, access, and political will across multiple regions and cannot be attributed to COVID-19 alone. The trajectory was already failing before the pandemic began, meaning the underlying systems designed to prevent transmission were insufficient even under normal conditions.
2. Marginalized Populations Bear a Disproportionate Burden
Byanyima noted that 62% of all new HIV infections occur among marginalized populations including men who have sex with men, sex workers, gay men, people who inject drugs, and incarcerated individuals. In at least 73 countries, laws criminalize same sex relationships. In 106 countries, personal drug use is criminalized. These legal environments directly obstruct access to prevention and treatment services and are a primary structural reason the global HIV AIDS 2020 targets cannot be met without simultaneously addressing human rights violations. As Byanyima stated, these are people whose rights are denied, and lifting those restrictions is inseparable from giving them the opportunity to benefit from science.
3. Women and Girls in Africa Account for 59% of New Infections
HIV continues to affect women and girls in Africa disproportionately, accounting for 59% of all new infections on the continent. Byanyima identified gender inequality, gender based violence, and structural barriers to personal safety as the underlying drivers. Girls are not safe in school or at home, she stated, and these conditions must be addressed in parallel with medical interventions if the global HIV AIDS 2020 targets are ever to be approached. The feminization of the HIV epidemic in Africa represents a human rights crisis as much as a public health one, and it demands responses that extend well beyond the healthcare system.
4. Regional Trends Are Moving in the Wrong Direction
While sub-Saharan Africa has reduced infections by 38% over the last decade, outpacing the global average reduction of 23%, other regions are moving in the opposite direction. Infections in Eastern Europe and Central Asia have increased by 72%. Latin America has seen a 21% rise. These divergences highlight that the global HIV AIDS 2020 targets cannot be achieved through progress in one region while others deteriorate. A truly global response requires addressing the specific legal, social, and economic conditions driving transmission in each region independently.
Signs of Progress Within the Crisis
There are meaningful bright spots within an otherwise alarming picture. The African nation of Eswatini, formerly known as Swaziland, has achieved not only the 90-90-90 targets but also the more ambitious 95-95-95 targets. This demonstrates that the global HIV AIDS 2020 targets framework is achievable when the right combination of political commitment, community health infrastructure, and sustained funding is in place.
In 2019, Botswana decriminalized same sex relationships, and legislative progress toward the same outcome is moving forward in Gabon. These legal changes matter because criminalization of same sex relationships and drug use is one of the most significant barriers to reaching the marginalized populations who account for nearly two thirds of new global infections. Progress on decriminalization is therefore direct progress toward the global HIV AIDS 2020 targets goals, even if the path is slow.
What Must Change to Get Back on Track
The COVID-19 pandemic has exposed and deepened the fragility of global HIV infrastructure. Supply chain disruptions, restricted travel, and the redirection of healthcare resources have all set back programs that took years to build. The path forward requires simultaneously rebuilding those community operations, addressing the legal environments that exclude marginalized populations, and ensuring that antiretroviral supply chains are resilient enough to withstand future disruptions.
As Byanyima concluded, there is progress, but not enough. The gap between where the world is and where the global HIV AIDS 2020 targets called for it to be is not simply a technical failure. It is a reflection of whose lives are treated as priorities and whose are not.
FOMAT conducts Phase I through Phase IV clinical research across a national network of investigator sites throughout the United States. To learn more about active infectious disease studies, visit our patient active studies page.